- Home
- XERS vs SPH Comparison
XERS vs SPH Comparison
Compare XERS & SPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- SPH
- Stock Information
- Founded
- XERS 2005
- SPH 1945
- Country
- XERS United States
- SPH United States
- Employees
- XERS N/A
- SPH N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- SPH Other Specialty Stores
- Sector
- XERS Health Care
- SPH Consumer Discretionary
- Exchange
- XERS Nasdaq
- SPH Nasdaq
- Market Cap
- XERS 1.3B
- SPH 1.2B
- IPO Year
- XERS 2018
- SPH 1996
- Fundamental
- Price
- XERS $7.64
- SPH $18.50
- Analyst Decision
- XERS Strong Buy
- SPH
- Analyst Count
- XERS 7
- SPH 0
- Target Price
- XERS $9.43
- SPH N/A
- AVG Volume (30 Days)
- XERS 3.0M
- SPH 128.0K
- Earning Date
- XERS 11-06-2025
- SPH 11-13-2025
- Dividend Yield
- XERS N/A
- SPH 7.00%
- EPS Growth
- XERS N/A
- SPH N/A
- EPS
- XERS N/A
- SPH 1.49
- Revenue
- XERS $266,137,000.00
- SPH $1,429,783,000.00
- Revenue This Year
- XERS $43.89
- SPH $10.99
- Revenue Next Year
- XERS $20.40
- SPH N/A
- P/E Ratio
- XERS N/A
- SPH $12.48
- Revenue Growth
- XERS 42.05
- SPH 6.29
- 52 Week Low
- XERS $2.82
- SPH $16.92
- 52 Week High
- XERS $10.08
- SPH $22.24
- Technical
- Relative Strength Index (RSI)
- XERS 36.31
- SPH 52.28
- Support Level
- XERS $7.00
- SPH $18.02
- Resistance Level
- XERS $10.08
- SPH $19.02
- Average True Range (ATR)
- XERS 0.53
- SPH 0.36
- MACD
- XERS -0.26
- SPH -0.03
- Stochastic Oscillator
- XERS 23.38
- SPH 65.48
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About SPH Suburban Propane Partners L.P.
Suburban Propane Partners LP distributes propane, fuel oil, and other refined fuels to customers in the East Coast and West Coast regions of the United States. Other operations include natural gas and electricity marketing in the deregulated New York and Pennsylvania markets. The company operates in three segments: Propane; Fuel Oil and Refined Fuels; and Natural Gas and Electricity. It generates maximum revenue from Propane segment.